Schroder Investment Management Group’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Schroder Investment Management Group’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-290,000	Closed	-$153K	–	1276
2024 Q4	$153K	Hold	290,000	–	–	﹤0.01%	1178
2024 Q3	$534K	Hold	290,000	–	–	﹤0.01%	1098
2024 Q2	$339K	Hold	290,000	–	–	﹤0.01%	1139
2024 Q1	$2.62M	Hold	290,000	–	–	﹤0.01%	886
2023 Q4	$3.15M	Buy	+290,000	New	+$2.17M	﹤0.01%	846

Schroder Investment Management Group's MRNS Position: Q1 2025 in Review

Schroder Investment Management Group sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 290,000 shares — an estimated $153K sold.

Schroder Investment Management Group first reported a position in MRNS in Q4 2023 and held it in 5 quarters. The position peaked at $3.15M in Q4 2023. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

Schroder Investment Management Group reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
Schroder Investment Management Group sold 290,000 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $153K.
Schroder Investment Management Group first reported a position in Marinus Pharmaceuticals, Inc in Q4 2023 and held it in 5 quarters.
Schroder Investment Management Group's Marinus Pharmaceuticals, Inc position peaked at $3.15M in Q4 2023.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Schroder Investment Management Group's 13F filing for Q1 2025, filed 13 May 2025.